12-month outcome and predictors of recurrence in psychiatric treatment of depression: a retrospective study
Many individuals treated for depression suffer relapse or recurrence after treatment. Known
risk factors include number of previous depressive episodes and residual symptoms after …
risk factors include number of previous depressive episodes and residual symptoms after …
Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
TI Mueller, AC Leon, MB Keller… - American Journal of …, 1999 - Am Psychiatric Assoc
OBJECTIVE: The recurrence of an affective disorder in people who initially recover from
major depressive disorder was characterized by using the unique longitudinal prospective …
major depressive disorder was characterized by using the unique longitudinal prospective …
Improvement within 2 weeks and later treatment outcomes in patients with depressive disorders: the CRESCEND study
BACKGROUND: Although antidepressants are conventionally given for 4–6weeks before
deciding on response, several reports suggest that early improvement predicts later …
deciding on response, several reports suggest that early improvement predicts later …
Recurrence of major depressive disorder and its predictors in the general population: results from The Netherlands Mental Health Survey and Incidence Study …
F Hardeveld, J Spijker, R De Graaf, WA Nolen… - Psychological …, 2013 - cambridge.org
BackgroundKnowledge of the risk of recurrence after recovery from major depressive
disorder (MDD) in the general population is scarce. MethodData were derived from 687 …
disorder (MDD) in the general population is scarce. MethodData were derived from 687 …
[HTML][HTML] Report by the ACNP Task Force on response and remission in major depressive disorder
This report summarizes recommendations from the ACNP Task Force on the
conceptualization of remission and its implications for defining recovery, relapse …
conceptualization of remission and its implications for defining recovery, relapse …
Predicting antidepressant response by monitoring early improvement of individual symptoms of depression: individual patient data meta-analysis
YA de Vries, AM Roest, EH Bos… - The British Journal of …, 2019 - cambridge.org
BackgroundImprovement in depression within the first 2 weeks of antidepressant treatment
predicts good outcomes, but non-improvers can still respond or remit, whereas improvers …
predicts good outcomes, but non-improvers can still respond or remit, whereas improvers …
The effect of prolonged duration of untreated depression on antidepressant treatment outcome
JD Bukh, C Bock, M Vinberg, LV Kessing - Journal of affective disorders, 2013 - Elsevier
BACKGROUND: The duration of untreated illness has been considered a likely predictor of
the course of psychotic disorders. However, there is only sparse data concerning the …
the course of psychotic disorders. However, there is only sparse data concerning the …
The prognostic significance of subsyndromal symptoms emerging after remission of late-life depression
DN Kiosses, GS Alexopoulos - Psychological medicine, 2013 - cambridge.org
BackgroundAttainment of remission is viewed as the optimal outcome of acute
antidepressant treatment. However, some patients experience subsyndromal symptoms …
antidepressant treatment. However, some patients experience subsyndromal symptoms …
Impact of subjective vs. objective remission status on subjective cognitive impairments in depression
K Sawada, K Yoshida, C Ozawa, Y Mizuno… - Journal of Affective …, 2019 - Elsevier
Objective The impact of subjective vs. objective illness severity on subjective cognitive
impairment in patients with depression has not been addressed. Methods This study is a …
impairment in patients with depression has not been addressed. Methods This study is a …
Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in …
N Iovieno, GI Papakostas - The Journal of clinical …, 2012 - legacy.psychiatrist.com
Results: The risk ratio of responding to the adjunctive drug versus placebo was not
influenced by any of the study design factors analyzed (probability of receiving placebo, year …
influenced by any of the study design factors analyzed (probability of receiving placebo, year …